Phase 3 Acute Ischemic Stroke AIS Clinical Trials
2 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–2 of 2 trials
Recruiting
Phase 2Phase 3
Exploration of the Efficacy and Mechanism of Galantamine (an Extract From Lycoris Aurea) in Treating Ischemic Stroke
Acute Ischemic Stroke AIS
Shanghai Yueyang Integrated Medicine Hospital66 enrolled1 locationNCT07003386
Recruiting
Phase 3
ACT-GLOBAL THROMBOLYSIS (ACT-WHEN-001) Domain Within the ACT-GLOBAL Adaptive Platform Trial-NCT06352632
Acute Ischemic Stroke AIS
University of Calgary4,000 enrolled24 locationsNCT06320431